PPARG and breast cancer: The decrease in PPARγ levels leads to the suppression of its downstream targets, FASN and PLIN4, which in turn reduces fatty acid synthesis and lipid droplet formation, potentially activating caspase-dependent apoptosis in luminal BC cells (Fig. 7C).